Amundi
MEDP icon

Amundi’s Medpace MEDP Stock Holding History

Amundi’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4M Sell
40,470
-20,669
-34% -$9.54M 0.01% 767
2026
Q1 		$29.4M Buy
61,139
+57,288
+1,488% +$29.3M 0.01% 701
2025
Q4 		$2.16M Sell
3,851
-19,406
-83% -$11M ﹤0.01% 1150
2025
Q3 		$12.3M Buy
23,257
+9,145
+65% +$3.99M ﹤0.01% 823
2025
Q2 		$4.6M Buy
14,112
+13,436
+1,988% +$4.03M ﹤0.01% 941
2025
Q1 		$206K Sell
676
-3,627
-84% -$1.22M ﹤0.01% 1672
2024
Q4 		$1.53M Buy
4,303
+65
+2% +$22K ﹤0.01% 1283
2024
Q3 		$1.43M Sell
4,238
-12,664
-75% -$4.81M ﹤0.01% 1215
2024
Q2 		$6.81M Sell
16,902
-371
-2% -$147K ﹤0.01% 910
2024
Q1 		$6.47M Buy
17,273
+2,864
+20% +$1.01M ﹤0.01% 917
2023
Q4 		$4.33M Sell
14,409
-8,465
-37% -$2.28M ﹤0.01% 1011
2023
Q3 		$5.47M Buy
22,874
+21,366
+1,417% +$5.46M ﹤0.01% 954
2023
Q2 		$360K Hold
1,508
– – ﹤0.01% 1460
2023
Q1 		$285K Sell
1,508
-105
-7% -$21.7K ﹤0.01% 1481
2022
Q4 		$366K Sell
1,613
-55
-3% -$11K ﹤0.01% 1446
2022
Q3 		$279K Hold
1,668
– – ﹤0.01% 1415
2022
Q2 		$247K Sell
1,668
-162
-9% -$23.5K ﹤0.01% 1341
2022
Q1 		$304K Sell
1,830
-357
-16% -$58.9K ﹤0.01% 1343
2021
Q4 		$394K Buy
2,187
+1,176
+116% +$246K ﹤0.01% 1418
2021
Q3 		$191K Sell
1,011
-35,708
-97% -$6.51M ﹤0.01% 1444
2021
Q2 		$6.49M Buy
+36,719
New +$6.34M ﹤0.01% 946

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Amundi's MEDP Position: Q2 2026 in Review

Amundi reduced its Medpace (MEDP) stake by 34% in Q2 2026, selling an estimated $9.54M and leaving 40,470 shares worth $21.4M. The position accounts for 0.01% of the portfolio, ranked #767.

Amundi first reported a position in MEDP in Q2 2021 and has held it in 21 quarters since. The position peaked at $29.4M in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Amundi held 40,470 shares of Medpace worth $21.4M as of Q2 2026.
  • Amundi sold 20,669 Medpace shares in Q2 2026, an estimated $9.54M.
  • Medpace made up 0.01% of Amundi's portfolio in Q2 2026, its #767 holding.
  • Amundi first reported a position in Medpace in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Medpace position peaked at $29.4M in Q1 2026.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.